Lipid based drug delivery systems comprising phospholipase A2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis

Details for Australian Patent Application No. 2007229160 (hide)

Owner LiPlasome Pharma A/S

Inventors Andresen, Thomas L.; Jorgensen, Kent

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007229160

PCT Pub. Number WO2007/107161

Priority PA 2006 00411 23.03.06 DK

Filing date 23 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/107161 Priority application(s): WO2007/107161

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229161-Small internally segmented interfering RNA

2007229157-Protection system for an electric generator, wind turbine and use hereof